Why the study?
Do PDE11A sequence defects predispose to adrenocortical tumors?
Population
117 adrenocortical tumors and 192 control subjects
Comparison
PDE11A gene sequencing, immunohistochemistry… vs 192 control subjects
Design
Case-control
Authors
Loading...
PDE11A variants were associated with adrenocortical tumors; hypothesis-generating for predisposition and requires validation before clinical consideration.
Do PDE11A sequence defects predispose to adrenocortical tumors?
PDE11A sequence defects are associated with a higher risk of various adrenocortical tumors, suggesting a genetic predisposition.
Libé et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: